The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease.
Mokhles MM, Trifirò G, Dieleman JP, Haag MD, van Soest EM, Verhamme KM, Mazzaglia G, Herings R, Luise Cd, Ross D, Brusselle G, Colao A, Haverkamp W, Schade R, Camp Gv, Zanettini R, Sturkenboom MC.
Mokhles MM, et al. Among authors: mazzaglia g.
Pharmacol Res. 2012 Mar;65(3):358-64. doi: 10.1016/j.phrs.2011.11.009. Epub 2011 Nov 23.
Pharmacol Res. 2012.
PMID: 22123498